Cumberland Pharmaceuticals Inc. Proceeds from Life Insurance Policy
Cumberland Pharmaceuticals Inc. (CPIX) reported Proceeds from Life Insurance Policy of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLifeInsurancePolicies · last filed 2026-03-09
- Cumberland Pharmaceuticals Inc. proceeds from life insurance policy for the quarter ending 2021-03-31 was -$200.00K.
- Cumberland Pharmaceuticals Inc. proceeds from life insurance policy for the quarter ending 2020-03-31 was $0.00.
- Cumberland Pharmaceuticals Inc. proceeds from life insurance policy for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Cumberland Pharmaceuticals Inc. proceeds from life insurance policy for fiscal 2024 was $237.56K, a 31.61% decline from fiscal 2023.
- Cumberland Pharmaceuticals Inc. proceeds from life insurance policy for fiscal 2023 was $347.36K, a 60.42% decline from fiscal 2022.
- Cumberland Pharmaceuticals Inc. proceeds from life insurance policy for fiscal 2022 was $877.60K.
| Period end | Proceeds from Life Insurance Policy 3 month | Proceeds from Life Insurance Policy 9 month | Proceeds from Life Insurance Policy 12 month | Proceeds from Life Insurance Policy 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-09 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | |||
| 2024-12-31 | $237.56K 10-K · filed 2026-03-09 | |||
| 2024-09-30 | $237.56K 10-Q · filed 2025-11-07 | |||
| 2023-12-31 | $347.36K 10-K · filed 2025-03-07 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | |||
| 2022-12-31 | $877.60K 10-K · filed 2024-03-13 | |||
| 2022-09-30 | $877.60K 10-Q · filed 2023-11-13 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-13 | $85.94K 10-K · filed 2022-03-11 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | |||
| 2021-03-31 | -$200.00K 10-Q · filed 2021-05-14 | |||
| 2020-12-31 | $460.89K 10-K · filed 2022-03-11 | |||
| 2020-09-30 | $460.89K 10-Q · filed 2020-11-13 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-14 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-11 | |||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-13 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |